Current Insights into Animal Models of Graves' Disease and Orbitopathy

被引:29
作者
Wiesweg, B. [1 ]
Johnson, K. T. M. [1 ]
Eckstein, A. K. [1 ]
Berchner-Pfannschmidt, U. [1 ]
机构
[1] Univ Duisburg Essen, Lab Mol Ophthalmol, Ctr Ophthalmol, Essen, Germany
关键词
murine models; autoimmunity; TSHR-antibodies; genetic immunization; mouse orbit; STIMULATING HORMONE-RECEPTOR; HUMAN THYROTROPIN RECEPTOR; THYROID EYE DISEASE; FACTOR-I RECEPTOR; GENETIC IMMUNIZATION; A-SUBUNIT; SIGNAL TRANSDUCER; KNOCKOUT MICE; OUTBRED MICE; MURINE MODEL;
D O I
10.1055/s-0033-1343451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease (GD) is a systemic autoimmune disease that is characterized by hyperthyroidism, orbitopathy and in rare cases dermopathy. Graves' orbitopathy (GO) is an inflammatory disease of eye and orbit which occurs in about 30-60% of patients. Hyperthyroidism occurs due to the presence of stimulating TSHR-autoantibodies (TRAbs) leading to increased serum levels of thyroid hormones. Attempts to induce Graves' disease in mice by immunization against the hTSHR or its variants have resulted in production of TRAbs that stimulate thyroid follicular cells to increase thyroid hormone secretion. Graves' like orbital changes, such as inflammation, adipogenesis and muscle fibrosis are more difficult to induce. In this review we summarize different methods used to induce murine Graves'-like disease and their impact on murine orbits.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 47 条
[1]   Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters [J].
Ando, T ;
Imaizumi, M ;
Graves, P ;
Unger, P ;
Davies, TF .
ENDOCRINOLOGY, 2003, 144 (02) :671-680
[2]   Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy [J].
Baker, G ;
Mazziotti, G ;
von Ruhland, C ;
Ludgate, M .
ENDOCRINOLOGY, 2005, 146 (02) :835-844
[3]  
BOTTAZZO GF, 1983, LANCET, V2, P1115
[4]   Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor [J].
Chazenbalk, GD ;
Pichurin, P ;
Chen, CR ;
Latrofa, F ;
Johnstone, AP ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) :209-217
[5]   Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease [J].
Chen, CR ;
Pichurin, P ;
Chazenbalk, GD ;
Aliesky, H ;
Nagayama, Y ;
McLachlan, SM ;
Rapoport, B .
ENDOCRINOLOGY, 2004, 145 (01) :228-233
[6]   The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim [J].
Chen, CR ;
Pichurin, P ;
Nagayama, Y ;
Latrofa, F ;
Rapoport, B ;
McLachlan, SM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1897-1904
[7]   Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease [J].
Costagliola, S ;
Many, MC ;
Denef, JF ;
Pohlenz, J ;
Refetoff, S ;
Vassart, G .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :803-811
[8]  
Costagliola S, 1998, J IMMUNOL, V160, P1458
[9]   INDUCTION OF THYROTROPIN RECEPTOR (TSH-R) AUTOANTIBODIES AND THYROIDITIS IN MICE IMMUNIZED WITH THE RECOMBINANT TSH-R [J].
COSTAGLIOLA, S ;
ALCALDE, L ;
TONACCHERA, M ;
RUF, J ;
VASSART, G ;
LUDGATE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (02) :1027-1034
[10]   Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease [J].
Eckstein, Anja K. ;
Plicht, Marco ;
Lax, Hildegard ;
Neuhaeuser, Markus ;
Mann, Klaus ;
Lederbogen, Sebastian ;
Heckmann, Christian ;
Esser, Joachim ;
Morgenthaler, Nils G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3464-3470